Article
Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro
22 Mar 2007
Abstract excerpt
Treatment of hepatitis C virus (HCV) infection has been met with less than satisfactory results due primarily to its resistance to and significant side effects from alpha interferon (IFN-alpha). New classes of safe and broadly acting treatments are urgently needed. Cyclosporine (CsA), an immunosuppressive and anti-inflammatory drug for organ transplant patients, has recently been shown to be highly effective in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
